Client Story

Trial Interactive Client Spotlight

Date Trial Interactive Expedites FDA Approval

TransPerfect assisted Karyopharm Therapeutics in expediting the FDA drug approval process for myeloma patients. Karyopharm approached TransPerfect with two challenges: preparing their trial master file (TMF) for inspections and translating over 60,000 words of critical documentation for an NDA submission within a weekend. Utilizing their Trial Interactive technology, TMF services, and translation expertise, TransPerfect enabled Karyopharm to meet the FDA's deadlines and successfully submit their drug application. As a result, Karyopharm's first product, XPOVIO, received FDA approval.

background image
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Webinar cover image
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.